Bata, Pfizer: These MNCs have up to 12% upside despite sanctions on Russia

Pfizer is near its long-term support, which it has defended for the last five years. A rebound can trigger a 10 per cent upside for the stock.

As Russia invades Ukraine in a fierce battle on the ground, the West - the US and the UK, have imposed heavy economic sanctions, while commodities prices have shot to multi-year highs. 

Brent Crude futures zoomed past the $121-level on fears of supply disruption, the highest levels since 2014. Other commodities like Gold and Aluminium too appear to be headed north.

The impositions of sanctions have instilled a dent in the Russian financial system, as it out now from the SWIFT payment structure. This is likely to have an adverse impact on its trades globally. The measures could